Kurt Goos

Kurt Goos - Partner

As a Partner at Marabek, Kurt brings more than 30 years of experience in the medical device industry and President/CEO level experience with both public and private medical device, manufacturing, software and telemedicine companies. He also has held a number of general management, M&A, marketing and business development positions with several leading medical device manufacturers, including St. Jude Medical, Medtronic, Carestream Health and LivaNova and most recently CEO of TheraTec.

Kurt has advised private equity firms on mergers, acquisitions and portfolio management ranging from large cap to start-ups in medical devices, telemedicine, medical software and contract manufacturing. Kurt brings extensive experience on both the buy- and sell-side M&A deal structuring for corporate and private equity investors seeking domestic and international opportunities.

He is well respected for his specialized expertise that extend beyond his strong executive leadership experiences,  Kurt is a strong advocate for carefully defined strategic Go-To-Market (GTM) planning and analytics and often leads with technical and scientific diligence with deep market intelligence and research. Kurt is often traveling to meet valued clients exploring corporate development opportunities and investments in early ventures, licensing and joint-venture strategies. His global network of senior level executives, directors of boards, multi-national companies and corporate investors uniquely qualify him to help find, execute and lead advanced manufacturing and innovative solutions within Marabek's medical device and med-tech practices.

Mr. Goos holds a Bachelor's degree in Marketing and Business Management from Minnesota State University and a Master's degree in Business Administration from the University of St. Thomas. He enjoys travel and time with his family and is active in the community and is active on several corporate and civic boards including AllerMed Pharmaceuticals, TheraTec, American Heart Association and American Cancer Society.